Gillian Tachibana

Impassioned by ethical digital pharma out-reach. I work in Neuroscience & Rare Diseases. Tweets expressed do not represent my employer.

[Roche @Roche]

We are passionate about putting people with #Alzheimers and their families at the centre of everything we do. This #WorldAlzMonth, our team shares how we will work with and support people with this disease:

[Gillian Tachibana @pharmaweb]

It’s World #AutismAwareness Day! #AutismAcceptance #neurodiversity https://t.co/5OBPah4Pa4

[Gillian Tachibana @pharmaweb]

Most importantly: #ClapForOurCarers

[Gillian Tachibana @pharmaweb]

#Coronavirus (#COVID-19) - #Apple and #CDC
Thank you .@Apple and .@CDCgov #washhands #stayhome #socialdistancing https://t.co/zRnvWARVdg

[Gillian Tachibana @pharmaweb]

#Coronavirus (#COVID-19) - #Apple and #CDC
Thank you .@Apple and .@CDCgov #washhands #stayhome #socialdistancing https://t.co/zRnvWARVdg

[Gillian Tachibana @pharmaweb]

Study suggests that screening for #ASD #Autism can improve but the 57% response rate from physicians and poor follow-through by parents means that there is still a long way to go via .@MedicalNewsBulletin https://t.co/kzmXJGyYWT

[Gillian Tachibana @pharmaweb]

Fantastic news for early #MSdiagnosis worth sharing! https://t.co/wpjOUg8Bl8

[Gillian Tachibana @pharmaweb]

Why do we not address this? Article: Aging Out of the System: Society’s Abandonment of #Autistic Adults https://t.co/KnstLtTTqt #siblingcaregivers #caregivers #autism #unconditionallove #mybrotherskeeper

[Gillian Tachibana @pharmaweb]

#WorldAutismDay: How #tech is empowering people with #autism in the workplace - Evening Standard #neurodiversity https://t.co/ZSQHY5Ioly

[Gillian Tachibana @pharmaweb]

Screen for #autism as early as 16 months, experts say - CBS News #AutismAwarenessMonth https://t.co/FQZmbK0deH

[Gillian Tachibana @pharmaweb]

12 innovations that will revolutionize the future of #medicine - National Geographic #DigitalHealth #mHealth #digiceutics https://t.co/H4uKzrqXmQ

[Gillian Tachibana @pharmaweb]

L’Oréal releases wearable UV exposure tracker with NFC and no battery https://t.co/qEJP40LsKQ via @VentureBeat #skincancer #mHealth

[Gillian Tachibana @pharmaweb]

Fantastic! #AppleWatch Series 4 is first consumer device to receive #FDA clearance for #ECG monitoring [u] https://t.co/TfWzrAx9om via @AppleInsider #mHealth #HeartHealth

[Gillian Tachibana @pharmaweb]

More #patients are taking home recordings of their #doctor visits. But who else could listen? https://t.co/h4JjfhFXMz #digitalhealth #dataprivacy

[Gillian Tachibana @pharmaweb]

PBS Kids and Zappos introduce adaptive apparel during #AutismAwarenessMonth https://t.co/h0CVmvjNtu via @thedrum

[Gillian Tachibana @pharmaweb]

Intereting study involving #autism. New #biomarkers to better identify subtypes of autism? https://t.co/0Z1om2ZFZN

[Gillian Tachibana @pharmaweb]

The Doctors of Tomorrow Will Be Supercomputers - Futurism #AI #aiHealth #digitalhealth https://t.co/YLIVLFv1nJ

[Gillian Tachibana @pharmaweb]

FDA clears AliveCor’s Kardiaband as the first #medicaldevice accessory for the #AppleWatch https://t.co/dUFYL71XtJ via @techcrunch #mHealth #medtech

[Gillian Tachibana @pharmaweb]

2M Computer Processing Hours Help Unearth New #Autism #Insights | https://t.co/OEm4e2rLMw via @HCA_News #digitalhealth

[Gillian Tachibana @pharmaweb]

Whole #genome sequencing identifies new genetic signature for #autism https://t.co/mHUfsTzcaY via @HHMINEWS @EurekAlert

[Gillian Tachibana @pharmaweb]

How the #GDPR will disrupt #Google and #Facebook - https://t.co/SpW31TIIs7 via @pagefair #dataprotection #dataprivacy